Cameco vs. Centrus vs. BWX Technologies: Ranking the 3 Nuclear Stocks That Get Paid Before a Reactor Is Built.
Cameco is one of the largest uranium miners. Centrus enriches a lot of that uranium.
Cameco is one of the largest uranium miners. Centrus enriches a lot of that uranium.
BWX (BWXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors need to pay close attention to BWX Technologies stock based on the movements in the options market lately.
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) issued the following statement clarifying recent news reports about a potential investment in Poland: While BWXT has been in discussions with government and industry in Poland regarding the deployment of microreactors and small modular reactors, no investment decision has been made and any investment would depend on firm orders and the extent of the opportunity. As Poland pursues energy security and resiliency, BWXT looks forw.
BWX Technologies, Inc. (NYSE: BWXT - Get Free Report) has received a consensus rating of "Moderate Buy" from the sixteen brokerages that are presently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation to the
Rising electricity demand and growing government support are fueling a nuclear energy resurgence. Centrus Energy aims to become a domestic producer of specialized nuclear fuel and is undergoing a capital-intensive build-out to do so.
The U.S. Army is spending $2.2 billion on nuclear microreactors to provide power for military bases. BWX Technologies (BWXT) is part of this U.S. Army nuclear energy project.
The AI revolution continues to create opportunities, with Taiwan Semiconductor (TSM), BWX Technologies (BWXT), and ASML Holding (ASML) each positioned to continue benefiting.
BWX (BWXT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The quickest way to add nuclear power to the U.S. grid is to get more out of the reactors already running. Over the past month, Google (GOOG) and Amazon (AMZN) signed agreements backing nearly 1.2 GW of uprates at existing plants.
BWX Technologies offers stability through critical nuclear infrastructure and strong government relationships. Rocket Lab provides high-growth potential through its vertically integrated launch and satellite service model.
BWX Technologies is rated Buy, leveraging its leadership in U.S. naval nuclear components and emerging commercial and military reactor opportunities. BWXT's recent underperformance and multiple compression have brought shares near Base case fair value, with a Bull case offering 32% upside. Key growth drivers include U.S. Navy procurement, data center nuclear fuel partnerships, and military microreactor projects, but risks stem from customer concentration and competitive threats.
During Q3 2026, the Polen 5Perspectives Small-Mid Growth Composite Portfolio returned -12.5% (net of fees) compared to the -10.4% return of the Russell 2500 Growth Index. The top contributors to the Portfolio's relative performance in the quarter were Twist Bioscience, Twilio, and Embraer. The most significant detractors from the Portfolio's relative performance in the quarter were nLight, Terawulf, and BWX Technologies.
BWX Technologies' nuclear growth, $1.4 billion in naval contracts and raised 2026 guidance bolster its outlook, but valuation, margin pressure and execution risks warrant caution.
BWX Technologies' 19.8% stock decline offers a more attractive entry point as nuclear demand and backlog grow, but valuation, margin pressure and execution risks warrant caution.
BWX Technologies raises its 2026 revenue, earnings and cash flow guidance as commercial nuclear growth surges, but margin pressure and fourth-quarter execution pose risks.
BWX Technologies (BWXT) is upgraded to Buy, with a YE27 price target of $183, offering 25% upside after a valuation reset. BWXT's core defense business provides stable, predictable cash flows, while commercial nuclear operations drive accelerating growth and margin expansion. Commercial segment revenue grew 63% in 2025 and is guided up 45% in 2026, with high-teens CAGR and EBITDA margin expansion targeted through 2030.
Leonardo DRS (NASDAQ: DRS - Get Free Report) and BWX Technologies (NYSE: BWXT - Get Free Report) are both industrials companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations. Profitability This table compares Leonardo DRS and BWX
Strong nuclear demand does not eliminate the very different execution risks facing different nuclear reactor stocks. Oklo, NuScale Power, and Nano Nuclear Energy still need execution to catch up with investor expectations.
BWX Technologies has manufactured components of compact naval reactors for decades. It is the only company licensed to provide nuclear components and nuclear fuel for the Navy.